Danske Bank’s AEON Biopharma AEON Stock Holding History

Danske Bank’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	1130
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1155
2025 Q4	$1	Hold	1	–	–	﹤0.01%	1544
2025 Q3	$1	Hold	1	–	–	﹤0.01%	1476
2025 Q2	$1	Hold	1	–	–	﹤0.01%	1506
2025 Q1	$1	Buy	+1	New	+$7	﹤0.01%	1352

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Danske Bank's AEON Position: Q2 2026 in Review

Danske Bank held its AEON Biopharma (AEON) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1130.

Danske Bank first reported a position in AEON in Q1 2025 and has held it in 6 quarters since. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

Danske Bank held 1 share of AEON Biopharma worth $1 as of Q2 2026.
Danske Bank left its AEON Biopharma share count unchanged in Q2 2026.
AEON Biopharma made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1130 holding.
Danske Bank first reported a position in AEON Biopharma in Q1 2025 and has held it in 6 quarters since.
22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.